Brookstone Capital Management Acquires 7,313 Shares of Procter & Gamble Company (The) $PG

Brookstone Capital Management grew its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 13.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 62,894 shares of the company’s stock after buying an additional 7,313 shares during the quarter. Brookstone Capital Management’s holdings in Procter & Gamble were worth $9,013,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. grew its position in Procter & Gamble by 0.6% during the 3rd quarter. Vanguard Group Inc. now owns 234,630,605 shares of the company’s stock worth $36,050,992,000 after acquiring an additional 1,419,322 shares during the last quarter. State Street Corp lifted its position in Procter & Gamble by 0.4% in the third quarter. State Street Corp now owns 100,634,824 shares of the company’s stock valued at $15,462,541,000 after purchasing an additional 370,872 shares during the last quarter. Franklin Resources Inc. lifted its position in Procter & Gamble by 8.3% in the third quarter. Franklin Resources Inc. now owns 22,850,345 shares of the company’s stock valued at $3,510,955,000 after purchasing an additional 1,752,481 shares during the last quarter. Legal & General Group Plc boosted its stake in shares of Procter & Gamble by 1.2% during the third quarter. Legal & General Group Plc now owns 16,556,061 shares of the company’s stock valued at $2,543,839,000 after purchasing an additional 189,968 shares during the period. Finally, Invesco Ltd. boosted its stake in shares of Procter & Gamble by 21.4% during the second quarter. Invesco Ltd. now owns 16,374,499 shares of the company’s stock valued at $2,608,785,000 after purchasing an additional 2,880,895 shares during the period. Institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In other news, insider Susan Street Whaley sold 1,809 shares of the firm’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $159.46, for a total transaction of $288,463.14. Following the sale, the insider owned 30,215 shares of the company’s stock, valued at $4,818,083.90. This trade represents a 5.65% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of Procter & Gamble stock in a transaction that occurred on Friday, February 13th. The stock was sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the completion of the sale, the insider directly owned 44,735 shares of the company’s stock, valued at approximately $7,259,595.80. This trade represents a 25.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 348,618 shares of company stock worth $55,462,643. Insiders own 0.20% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on PG shares. Erste Group Bank downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Tuesday, March 24th. Rothschild & Co Redburn increased their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “neutral” rating in a research report on Friday, January 23rd. Barclays set a $155.00 price target on shares of Procter & Gamble in a report on Friday, January 16th. Wells Fargo & Company restated an “overweight” rating and set a $177.00 price target on shares of Procter & Gamble in a report on Tuesday, February 17th. Finally, BNP Paribas Exane dropped their price objective on Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating for the company in a report on Friday, January 16th. Twelve research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $167.83.

Procter & Gamble Trading Down 0.2%

Shares of NYSE PG opened at $144.44 on Wednesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51. The firm has a 50-day moving average of $153.88 and a 200 day moving average of $149.88. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $174.80. The stock has a market cap of $335.67 billion, a P/E ratio of 21.40, a price-to-earnings-growth ratio of 4.84 and a beta of 0.37.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, January 23rd. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The company had revenue of $22.21 billion for the quarter, compared to the consensus estimate of $22.36 billion. During the same quarter in the prior year, the business posted $1.88 EPS. The firm’s quarterly revenue was up 1.5% compared to the same quarter last year. As a group, sell-side analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were paid a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. The ex-dividend date was Friday, January 23rd. Procter & Gamble’s dividend payout ratio is currently 62.52%.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: OLAY peptide research — New clinical and mechanistic data presented for OLAY highlight proprietary peptide technology and cell‑adhesion targets that P&G plans to move rapidly into formulations; successful commercialization could bolster pricing power and organic growth for a core beauty brand. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
• Positive Sentiment: Analysts remain constructive in places — coverage notes that P&G can fare better than peers amid sluggish consumer sentiment, supporting the view of PG as a relatively defensive consumer staples holding. Analysts Constructive on The Procter & Gamble (PG) Amid Sluggish Consumer Sentiment
• Neutral Sentiment: Recent trading strength — PG ticked higher while the broader market fell on 3/30, showing relative strength that may reflect defensive demand; however this was a short‑term move rather than new fundamental news. Procter & Gamble (PG) Ascends While Market Falls: Some Facts to Note
• Neutral Sentiment: Q4 results mixed — Q4 EPS slightly beat estimates (+$0.02) while revenue marginally missed; steady margins and cash flow help the case for the dividend and buybacks, but top‑line softness tempers upside. (Earnings detail from recent company report.)
• Neutral Sentiment: Deutsche Bank trimmed its price target (from $171 to $162) but kept a Hold — this narrows upside but is not a sell signal; investors should weigh this against other analyst views. Deutsche Bank Lowers Price Target on PG
• Neutral Sentiment: Unrelated retailer weakness — a separate report on RH’s weak quarter is unlikely to directly affect PG but signals broader discretionary‑spending challenges in retail. RH (RH) Lags Q4 Earnings and Revenue Estimates
• Negative Sentiment: TD Cowen cut its price target to $142 (from $156) and kept a Hold, citing oil‑linked input cost inflation tied to the Iran war that it believes P&G cannot fully absorb — this is the main near‑term headwind pressuring the stock. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.